株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

セラノスティクス市場の予測:疾患別 (神経障害、癌、心血管疾患)、地域別

Theranostics Market - Forecast (2020 - 2025)

発行 IndustryARC 商品コード 422607
出版日 ページ情報 英文 103 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=109.95円で換算しております。
セラノスティクス市場の予測:疾患別 (神経障害、癌、心血管疾患)、地域別 Theranostics Market - Forecast (2020 - 2025)
出版日: 2020年03月11日 ページ情報: 英文 103 Pages
概要

当レポートでは、世界のセラノスティクス市場について調査分析し、市場情勢、市場力学、戦略的分析、市場分析 (セグメント別) のほか、市場エントロピー、主要企業など、体系的な情報を提供しています。

第1章 セラノスティクス市場:概要

第2章 エグゼクティブサマリー

第3章 市場情勢

  • 市場シェア分析
  • 比較分析
  • 製品ベンチマーキング
  • エンドユーザープロファイリング
  • 5大財務分析

第4章 セラノスティクス市場:力学

  • 促進要因
  • 抑制要因
  • 機会
  • 課題
  • ファイブフォース分析

第5章 セラノスティクス市場:戦略的分析

  • バリューチェーン分析
  • 価格分析
  • 機会分析
  • 製品/市場ライフサイクル分析
  • サプライヤーと販売業者

第6章 セラノスティクス市場:疾患別

  • 神経障害
  • 心血管疾患

第7章 セラノスティクス市場:地域別

  • 欧州
  • アジア太平洋地域
  • 北米
  • その他

第8章 セラノスティクス市場:エントロピー

  • 事業拡大
  • 技術開発
  • M&A、合弁事業
  • 供給契約

第9章 企業プロファイル

  • Abbott Laboratories
  • AmeriPath
  • Beckman Coulter
  • Dickinson & Company
  • BIOTEC Laboratories
  • Center for Disease Control and Prevention (CDC)
  • Dade Behring
  • Dianon Systems
  • Dynacare Laboratories
  • Enterix
  • EntroGen
  • Esoterix
  • Focus Diagnostics
  • Pfizer

第10章 付録

目次
Product Code: HCR 0396

Theranostics can be defined as the fusion of drug therapy and diagnostics to optimize effectiveness, safety, and streamline drug development. It is the combination of medical drugs with diagnostic tests and is also known as integrated medicine, pharmacodiagnostics, companion diagnostics, and Dx/Rx partnering. Theranostics involves association of diagnostics along with drug therapy in order to streamline the development of a drug which is more effective and cheaper. According to WHO, every year nearly 1o million new cases of cancer are being registered and cancer has become one of the major concern for the healthcare industry and it has become the need of the hour to develop an effective drug with minimum side effects which requires strong co-ordination between drug developers and diagnostic industry. Theranascostics is an emerging field, which is generating a strong interest from regulatory bodies and healthcare industries market.

Theranostics Market

Geographically, North America dominates the theranostics market driven by best in class healthcare and pharmaceutical infrastructure, best in industry practices, strict regulation and high degree of adherence to the rules and guidelines. North America was followed by Europe and Asia-Pacific as second and third largests market for the theranostics market. Asia Pacific is projected to have the fastest growth, owing to rapidly developing medical infrastructure, increasing medical tourism, newer regulations implementations by governing bodies, and increasing awareness amongst population in developing nations such as China and India in this region.

This report identifies the global theranostics market size in for the year 2020-2025, and forecast of the same for year 2021. It also highlights the market drivers, restraints, growth indicators, challenges, and other key aspects with respect to the theranostics market.

This report segments the theranostics market on the basis of diseases and regional market as follows:

Theranostics Market research report is classified on the basis of diseases. Some of the major diseases covered in this report are as follows: Neuro Disorders, Cancers and Cardiovascular diseases

This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region

This report identifies all the major companies operating in the theranostics market. Some of the major companies' profiles in detail are as follows:

Abbott Laboratories

AmeriPath

Beckman Coulter

Dickinson & Company

BIOTEC Laboratories

1. Theranostics Market - Overview

  • 1.1. Definitions and Scope

2. Theranostics Market - Executive summary

  • 2.1. Market Revenue, Market Size and Key Trends by Company
  • 2.2. Key Trends by type of Application
  • 2.3. Key Trends segmented by Geography

3. Theranostics Market

  • 3.1. Comparative analysis
    • 3.1.1. Product Benchmarking - Top 8 companies
    • 3.1.2. Top 5 Financials Analysis
    • 3.1.3. Market Value split by Top 8 companies
    • 3.1.4. Patent Analysis - Top 8 companies
    • 3.1.5. Pricing Analysis

4. Theranostics Market Forces

  • 4.1. Drivers
  • 4.2. Constraints
  • 4.3. Challenges
  • 4.4. Porters five force model
    • 4.4.1. Bargaining power of suppliers
    • 4.4.2. Bargaining powers of customers
    • 4.4.3. Threat of new entrants
    • 4.4.4. Rivalry among existing players
    • 4.4.5. Threat of substitutes

5. Theranostics Market -Strategic analysis

  • 5.1. Value chain analysis
  • 5.2. Opportunities analysis
  • 5.3. Product life cycle
  • 5.4. Suppliers and distributors Market Share

6. Theranostics Market - By Diseases (Market Size -$Million / $Billion)

  • 6.1. Market Size and Market Share Analysis
  • 6.2. Application Revenue and Trend Research
  • 6.3. Product Segment Analysis
    • 6.3.1. Neuro Disorders
    • 6.3.2. Cancers
    • 6.3.3. Cardiovascular Diseases

7. Theranostics - By Geography (Market Size -$Million / $Billion)

  • 7.1. Theranostics Market - North America Segment Research
  • 7.2. North America Market Research (Million / $Billion)
    • 7.2.1. Segment type Size and Market Size Analysis
    • 7.2.2. Revenue and Trends
    • 7.2.3. Application Revenue and Trends by type of Application
    • 7.2.4. Company Revenue and Product Analysis
    • 7.2.5. North America Product type and Application Market Size
      • 7.2.5.1. U.S.
      • 7.2.5.2. Canada
      • 7.2.5.3. Mexico
      • 7.2.5.4. Rest of North America
  • 7.3. Theranostics - South America Segment Research
  • 7.4. South America Market Research (Market Size -$Million / $Billion)
    • 7.4.1. Segment type Size and Market Size Analysis
    • 7.4.2. Revenue and Trends
    • 7.4.3. Application Revenue and Trends by type of Application
    • 7.4.4. Company Revenue and Product Analysis
    • 7.4.5. South America Product type and Application Market Size
      • 7.4.5.1. Brazil
      • 7.4.5.2. Venezuela
      • 7.4.5.3. Argentina
      • 7.4.5.4. Ecuador
      • 7.4.5.5. Peru
      • 7.4.5.6. Colombia
      • 7.4.5.7. Costa Rica
      • 7.4.5.8. Rest of South America
  • 7.5. Theranostics - Europe Segment Research
  • 7.6. Europe Market Research (Market Size -$Million / $Billion)
    • 7.6.1. Segment type Size and Market Size Analysis
    • 7.6.2. Revenue and Trends
    • 7.6.3. Application Revenue and Trends by type of Application
    • 7.6.4. Company Revenue and Product Analysis
    • 7.6.5. Europe Segment Product type and Application Market Size
      • 7.6.5.1. U.K
      • 7.6.5.2. Germany
      • 7.6.5.3. Italy
      • 7.6.5.4. France
      • 7.6.5.5. Netherlands
      • 7.6.5.6. Belgium
      • 7.6.5.7. Spain
      • 7.6.5.8. Denmark
      • 7.6.5.7. Rest of Europe
  • 7.7. Theranostics - APAC Segment Research
  • 7.8. APAC Market Research (Market Size -$Million / $Billion)
    • 7.8.1. Segment type Size and Market Size Analysis
    • 7.8.2. Revenue and Trends
    • 7.8.3. Application Revenue and Trends by type of Application
    • 7.8.4. Company Revenue and Product Analysis
    • 7.8.5. APAC Segment - Product type and Application Market Size
      • 7.8.5.1. China
      • 7.8.5.2. Australia
      • 7.8.5.3. Japan
      • 7.8.5.4. South Korea
      • 7.8.5.5. India
      • 7.8.5.6. Taiwan
      • 7.8.5.7. Malaysia

8. Theranostics Market - Entropy

  • 8.1. New product launches
  • 8.2. M&A's, collaborations, JVs and partnerships

9. Theranostics Market Company Analysis

  • 9.1. Market Share, Company Revenue, Products, M&A, Developments
  • 9.2. Abbott Laboratories
  • 9.3. AmeriPath
  • 9.4. Beckman Coulter
  • 9.5. Dickinson & Company
  • 9.6. BIOTEC Laboratories
  • 9.7. Center for Disease Control and Prevention (CDC)
  • 9.8. Dade Behring
  • 9.9. Dianon Systems
  • 9.8. Dynacare Laboratories
  • 9.11. Enterix
  • 9.12. EntroGen
  • 9.9. Esoterix
  • 9.10. Focus Diagnostics
  • 9.15. Pfizer
  • 9.16. Company 16
  • 9.17. Company 17
  • 9.18. Company 18 and more

"*Financials would be provided on a best efforts basis for private companies"

10. Theranostics Market -Appendix

  • 10.1. Abbreviations
  • 10.2. Sources